Skip to main content
Jazz Investments I Limited, $575,000,000 1.50% Exchangeable Senior Notes due 15 August 2024
International Debt

This security is no longer listed on the BSX and its details are no longer maintained by the BSX. The information on this page is believed to be correct at date of delisting.

Domicile
Bermuda
Listing Date
Delisting Date
Currency
USD
Maturity Date
Investors
Qualified Investors
Listing Sponsor
First Bermuda Securities Limited
ISIN
US472145AC52
CUSIP
472145AC5
Status
Delisted

Financial & Other Information:

Date Title
2024-06-26 2023 Financials
2024-01-15 Jazz Pharmaceuticals PLC 2023 - Q3 10-Q
2024-01-15 Jazz Pharmaceuticals PLC 2023 - Q2 10-Q
2024-01-15 Jazz Pharmaceuticals PLC 2023 - Q1 10-Q
2024-01-15 2022 Financials
2024-01-15 Jazz Pharmaceuticals PLC 2022 - Q3 10-Q
2024-01-15 Jazz Pharmaceuticals PLC 2022 - Q2 10-Q
2024-01-15 Jazz Pharmaceuticals PLC 2022 - Q1 10-Q
2022-03-02 2021 Financials
2021-11-16 Jazz Pharmaceuticals PLC 2021 Q3 10-Q
2021-11-16 Jazz Pharmaceuticals PLC 2021 Q2 10-Q
2021-11-16 Jazz Pharmaceuticals PLC 2021 Q1 10-Q
2021-02-24 2020 Financials
2020-11-03 Jazz Pharmaceuticals PLC 2020 Q3 10-Q
2020-11-03 Jazz Pharmaceuticals PLC 2020 Q2 10-Q
2020-05-06 Jazz Pharmaceuticals PLC 2020 Q1 10-Q
2020-02-26 2019 Financials
2019-08-08 2019 Q2 Interim Financials-10-Q
2019-08-08 2018 Proxy and Annual Report
2019-05-08 Jazz Pharmaceuticals PLC 2019 Q1 10-Q
2019-05-08 Jazz Pharmaceuticals PLC 2019 Q1 Report
2019-03-04 Jazz Pharmaceuticals PLC 2018 Annual Report
2018-11-07 2018 Q3 Financial Report
2018-09-18 2018 Q2 Interim Financials-10-Q
2018-08-14 2017 Proxy and Annual Report
2018-03-05 2017 Financials
2018-03-02 Jazz Pharmaceuticals PLC 2017 Annual Report